| | DIHYDROCODEINE TRIFLUOROACETATE Basic information |
| Product Name: | DIHYDROCODEINE TRIFLUOROACETATE | | Synonyms: | 4,5-alpha-epoxy-3-methoxy-17-methyl-morphinan-6-alpha-o;4,5alpha-Epoxy-3-methoxy-17-methylmorphinan-6alpha-ol;6-alpha-hydrocodol;6α-Hydrocodol;Codeine, 7,8-dihydro- (6CI);Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5α,6α)-;Morphinan-6α-ol, 4,5α-epoxy-3-methoxy-17-methyl- (8CI);NSC 231319 | | CAS: | 125-28-0 | | MF: | C20H24F3NO4 | | MW: | 399.4 | | EINECS: | 204-732-3 | | Product Categories: | | | Mol File: | 125-28-0.mol |  |
| | DIHYDROCODEINE TRIFLUOROACETATE Chemical Properties |
| | DIHYDROCODEINE TRIFLUOROACETATE Usage And Synthesis |
| Originator | Bicodein,Uquifa | | Definition | ChEBI: Dihydrocodeine is a morphinane alkaloid. | | Manufacturing Process | The codein was reduced by hydrogen in the presence catalyst Pt (or Pd, or Ni)
and 7,8-dihydrocodein was obtained.
To the 7,8-dihydrocodein tartaric acid was added and mixed, in the result 7,8-
dihydrocodein bitartrate was obtained. | | Therapeutic Function | Antitussive, Narcotic analgesic | | Safety Profile | Poison by ingestion,
intravenous, and subcutaneous routes.
Human systemic effects by ingestion and
subcutaneous routes: somnolence, miosis
(pupillary constriction), and respiratory
depression. An analgesic. Can cause drug
dependency with repeated doses. When
heated to decomposition it emits toxic
fumes of NOx. See also CODEINE. |
| | DIHYDROCODEINE TRIFLUOROACETATE Preparation Products And Raw materials |
|